Bentysrepinine, formerly known as Y-101, is a novel anti-HBV agent inhibiting DNA-HBV and cccDNA activities for the treatment of hepatitis B virus (HBV)-infected hepatitis. References: Fan H, Li R, Gu Y, Si D, Liu C. Quantitation of bentysrepinine (Y101) in rat plasma by liquid chromatography tandem mass spectrometry: application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:103-9. doi: 10.1016/j.jchromb.2012.02.002. PubMed PMID: 22366283.

纯度：≥98%

CAS：934264-38-7